Atellica IM CA 125II 10995481Recalls & reported problems
Siemens Healthcare Diagnostics Inc. · CA 125II Atellica IM - RGT 100T · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00630414598086), received between Jun 3, 2021 and Jun 20, 2025 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Low Test Results” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Low Test Results2
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 20, 2025Low Test Results; Low Test Results
THE CUSTOMER OBSERVED A BIAS IN ATELLICA IM CA 125II PATIENT RESULTS BETWEEN REAGENT LOT 223 AND 221. THIS WAS IDENTIFIED WHEN THE CUSTOMER WAS PERFORMING LOT TO LOT COMPARISONS AS PART OF THEIR LAB PROCESS WHEN CHANGING REAGENT LOTS (FROM LOT 221 TO LOT 223). THE CUSTOMER STATES THAT QUALITY CONTROL (QC) WAS IN RANGE AND NO PATIENTS GENERATED WITH LOT 221 WERE QUESTIONED BY PHYSICIANS; THERE IS NO INDICATION THAT ERRONEOUS RESULTS CA125II PATIENT RESULTS WERE REPORTED. THERE ARE NO ALLEGATIONS OF PATIENT HARM, CHANGES IN TREATMENT, OR DELAYS OF DIAGNOSIS IN ASSOCIATION WITH THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22302080 ↗MalfunctionJun 3, 2021Low Test Results; Low Test Results
A DISCORDANT LOW ATELLICA IM CA 125II (CA 125II) RESULT WAS OBTAINED ON A PATIENT SAMPLE. THE CUSTOMER WHEN PERFORMING A ROUTINE QUALITY CONTROL (QC) CHECK OBSERVED AN OUT OF RANGE LOW QC RESULT THAT REQUIRED AN ASSAY RECALIBRATION TO RESOLVE. THE CUSTOMER PERFORMED REPEATED TESTING ON THE ONLY PATIENT SAMPLE THAT WAS RUN PRIOR TO THE ROUTINE QC CHECK. THE PATIENT SAMPLE WHEN REPEATED RESULTED HIGHER. THE HIGHER CA 125II WAS REPORTED AS THE CORRECTED RESULT TO THE PHYSICIAN(S). THERE ARE NO REPORTS THAT TREATMENT WAS ALTERED OR PRESCRIBED OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT, LOW ATELLICA IM CA 125II RESULT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11930989 ↗
Other TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125) devices
- ADVIA Centaur® CA 125II 10310443Siemens Healthcare Diagnostics Inc. · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)1 recall10 reports
- ADVIA Centaur® CA 125 II 10315696Siemens Healthcare Diagnostics Inc. · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)1 recall0 reports
- ARCHITECT 02K4529Abbott GmbH · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)8 reports
- Atellica IM CA 125II 10995482Siemens Healthcare Diagnostics Inc. · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)3 reports
- ARCHITECT 02K4539Abbott GmbH · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)3 reports
- Alinity 08P4920Abbott GmbH · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)2 reports
- Alinity 08P4930Abbott GmbH · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)2 reports
- Elecsys CA 125 II Assay 11776223161Roche Diagnostics GmbH · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)2 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page